Anti-CD9 antibody [EPR23105-121]
Anti-CD9 항체 [EPR23105-121]
- 20ul selling size
- BOND RX™ Validated
- RabMAb
- Recombinant
- KO Validated
- 각 태그의 뜻
5
(4 리뷰들)
|
(190 제품이 사용된 논문 )
Anti-CD9 antibody [EPR23105-121] (ab236630) is a rabbit monoclonal antibody detecting CD9 in Western Blot, Flow Cytometry, IP, IHC-P, ICC/IF. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications
대체 명칭 보기
CD9, MIC3, TSPAN29, GIG2, CD9 antigen, 5H9 antigen, Cell growth-inhibiting gene 2 protein, Leukocyte antigen MIC3, Motility-related protein, Tetraspanin-29, p24, MRP-1, Tspan-29
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD9 antibody [EPR23105-121] (AB236630)
Immunohistochemical analysis of paraffin-embedded Human bladder carcinoma tissue labeling CD9 with ab236630 at 1/100 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on human bladder carcinoma. The section was incubated with ab236630 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20mins.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD9 antibody [EPR23105-121] (AB236630)
Immunohistochemical analysis of formalin fixed paraffin embedded human bladder carcinoma labelling CD9 with ab236630 at a concentration of 0.5 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH 8.5 for 32mins.
ab236630 anti-CD9 [EPR23105-121] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CD9 antibody [EPR23105-121] (AB236630)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HCT 116 (human colorectal carcinoma epithelial cell) cells labelling CD9 with ab236630 at 1/500 dilution, followed by ab150077 AlexaFluor®488 Goat anti-Rabbit secondary antibody at 1/1000 dilution (Green). Confocal image showing membranous staining in HCT 116 cell line. Negative control : Raji (PMID : 8921952). ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150077 AlexaFluor®488 Goat anti-Rabbit secondary at 1/1000 dilution.
- Flow Cyt
Unknown
Flow Cytometry - Anti-CD9 antibody [EPR23105-121] (AB236630)
Flow cytometric analysis of Raji (human Burkitt's lymphoma B lymphocyte, Left) / HCT 116 (human colorectal carcinoma epithelial cell, Right) cells labelling CD9 with ab236630 at 1/50 dilution compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 was used as the secondary antibody.
Negative control : Raji (PMID : 8921952).
Gated on viable cells.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD9 antibody [EPR23105-121] (AB236630)
Immunohistochemical analysis of paraffin-embedded Human spleen tissue labeling CD9 with ab236630 at 1/100 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining on platelets of human spleen. The section was incubated with ab236630 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20mins.
- Flow Cyt
Lab
Flow Cytometry - Anti-CD9 antibody [EPR23105-121] (AB236630)
Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) with ab236630 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left).
PBMCs were incubated for 30 min on ice in 1x PBS containing 10 µg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interaction followed by the antibody ab236630 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 106 in 100 µl at 0.2 μg/ml (1/10,500)) for 30min on ice.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/2000 for 30min on ice.
Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on live cells.
- IP
Unknown
Immunoprecipitation - Anti-CD9 antibody [EPR23105-121] (AB236630)
CD9 was immunoprecipitated from 0.35 mg HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate with ab236630 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab236630 at 1/500 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/1000 dilution.
Lane 1 : HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate 10ug.
Lane 2 : ab236630 IP in HCT 116 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab236630 in HCT 116 whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-CD9 antibody [EPR23105-121] (ab236630)
Predicted band size: 25 kDa
Observed band size: 22 kDa
false
- WB
Lab
Western blot - Anti-CD9 antibody [EPR23105-121] (AB236630)
Lanes 1 - 4 : Merged signal (red and green). Green - ab236630 observed at 18 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.
ab236630 was shown to react with CD9 in wild-type HeLa cells in Western blot with loss of signal observed in CD9 knockout cell line ab255375 (CD9 knockout cell lysate ab263754). Wild-type HeLa and CD9 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with ab236630 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-CD9 antibody [EPR23105-121] (ab236630) at 1/1000 dilution
Lane 1:
Wild-type HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
CD9 knockout HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CD9 knockout HeLa cell line (<a href='/ko/products/cell-lines/human-cd9-knockout-hela-cell-line-ab255375'>ab255375</a>)
Lane 3:
A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Predicted band size: 25 kDa
Observed band size: 18 kDa
false
- WB
Lab
Western blot - Anti-CD9 antibody [EPR23105-121] (AB236630)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 3275469). Exposure time : 3 minutes.
All lanes:
Western blot - Anti-CD9 antibody [EPR23105-121] (ab236630) at 1/1000 dilution
Lane 1:
Human tonsil lysate at 20 µg
Lane 2:
Human colon lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 25 kDa
Observed band size: 22 kDa
false
- WB
Lab
Western blot - Anti-CD9 antibody [EPR23105-121] (AB236630)
Blocking and diluting buffer and concentration : 5% NFDM/TBST This blot was developed using a higher sensitivity ECL substrate. The molecular weight observed is consistent with what has been described in the literature (PMID : 3275469).
Negative control : Raji (PMID : 8921952). Exposure time : 3 minutes
All lanes:
Western blot - Anti-CD9 antibody [EPR23105-121] (ab236630) at 1/1000 dilution
Lane 1:
HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Raji (human Burkitts lymphoma b lymphocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 25 kDa
Observed band size: 22 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (3)
-
Anti-CD9 antibody [EPR23105-121] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD9 antibody [EPR23105-121]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD9 antibody [EPR23105-121]
Reactivity 정보
제품 세부 정보
Product Specifications
Anti-CD9 antibody [EPR23105-121] (ab236630) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt, ICC/IF, IHC-P, IP, WB in human samples.
Anti-CD9 antibody [EPR23105-121] (ab236630) specifically detects CD9 (UniProt ID: P21926; Molecular weight: 25kDa) and is sold in 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-CD9 antibody [EPR23105-121] (ab236630) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-CD9 antibody [EPR23105-121] (ab236630) has been confirmed by testing in knockout samples.
Anti-CD9 antibody [EPR23105-121] (ab236630) has been cited over 65 times in peer reviewed journals and is trusted by the scientific community.
Related Products
Conjugation-ready, carrier free format available for antibody clone EPR23105-121 - ab263023.
Antibody clone EPR23105-121 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647 (ab267502, ab267503).
Target Information
CD9 also known as p24 is a member of the tetraspanin family, which includes proteins involved in various cellular processes. CD9 (p24) plays a significant role in cancer progression and metastasis by influencing cell adhesion, migration, and signaling. CD9 (p24) is found on the surface of cancer cells and within exosomes, impacting cancer progression and therapy resistance. CD9's role in cancer is complex, as it can both suppress and promote tumor growth depending on the context. The protein's interactions within tetraspanin-enriched microdomains (TEMs) are crucial for its function.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The CD9 protein is integral to cell adhesion migration and fusion. It forms complexes with other tetraspanins and proteins like EWI-2 and EWI-F contributing to cellular signaling and membrane compartmentalization. Additionally CD9 plays an important role in the formation and secretion of exosomes tiny vesicles emitted by cells that mediate cell-to-cell communication. These exosomes can be analyzed using tools like exosome assays and detection kits that target CD9 proteins.
Pathways
CD9 is involved in the regulation of immune response and cell morphology. It participates in pathways such as the integrin signaling pathway and the phosphatidylinositol 3-kinase (PI3K) signaling pathway. CD9 modulates these interactions by associating with proteins such as integrins and other members of the tetraspanin family influencing cellular movement and proliferation.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
제품이 사용된 논문 (190)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Experimental and therapeutic medicine 30:224 PubMed41018883
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research and treatment : PubMed40997931
2025
Applications
Unspecified application
Species
Unspecified reactive species
Brazilian journal of otorhinolaryngology 91:101703 PubMed40916258
2025
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 17: PubMed40872854
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 23:348 PubMed40691620
2025
Applications
Unspecified application
Species
Unspecified reactive species
Regenerative therapy 30:321-332 PubMed40689375
2025
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 16:382 PubMed40671164
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 23:504 PubMed40652239
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 12:1600429 PubMed40636359
2025
Applications
Unspecified application
Species
Unspecified reactive species
Human cell 38:124 PubMed40614007
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com